Astrazeneca PLC (AZN) News
Filter AZN News Items
AZN News Results
|Event/Time||Symbol||Company||News Detail||Start||End||Change||POWR Rating|
|Loading, please wait...|
Latest AZN News From Around the Web
Below are the latest news stories about Astrazeneca Plc that investors may wish to consider to help them evaluate AZN as an investment opportunity.
The FDA has granted Breakthrough Therapy Designation to AstraZeneca’s (AZN) Farxiga for the treatment of patients with chronic kidney disease, with and without type-2 diabetes.Breakthrough Therapy status provides for more intensive guidance from the FDA on development, the involvement of more senior agency personnel and a rolling review of the...
Following a review of safety data by an independent committee, a Phase 1/2 clinical trial evaluating AstraZeneca's (AZN) COVID-19 vaccine candidate, AZD1222, has resumed in Japan following earlier restarts in the U.K., Brazil, South Africa and India.The U.S. study has yet to resume....
Canadian biotech IMV Inc. (IMV) can rely on government and industry financial support totaling $3.58 million to continue the development of its experimental vaccine against the new coronavirus. IMV has a market cap of $306 million. This support is essential in enabling the Nova Scotia-based company to perform clinical trials...
Quick Take Shattuck Labs (STTK) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The firm is a clinical stage biopharma advancing programs to treat ovarian cancer and other cancers. STTK has produced intriguing early stage safety and efficacy results....
No summary available.
No summary available.
Trials on the coronavirus vaccine developed by AstraZeneca and Oxford University have resumed in Japan but not the United States, where the pharmaceutical giant is working with regulators, a statement released said.
AstraZeneca has applied for Canadian regulatory approval for the so-called Oxford vaccine, becoming the first company to do so. But don’t expect a finished vaccine just yet
Following the earlier suspension, AstraZeneca (AZN) disclosed that it received authorization to resume COVID-19 vaccine trial in Japan.
Moderna, Pfizer & BioNTech, and AstraZeneca and the University of Oxford's COVID-19 Vaccine Trials are Entering the Final Stage of Development
DUBLIN, Oct. 2, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the vaccine industry "COVID-19 Vaccine Trials are Entering the Final Stage of Development" Johnson & Johnson has begun final stage testing of its COVID-19 vaccine candidate. The company will trial the…